Jaguar Animal Health Nachrichten und Aktivitäten

Jaguar Animal Health ist ein Unternehmen, das unter dem Börsenticker JAGX (US) gelistet ist.

Jaguar Animal Health hat eine direkte Präsenz in 2 Ländern.

Sie befinden sich in:

• Gesundheitswesen67%
• Pharmazie33%

Siehe das Organigramm mit seine 24 wichtigsten Führungskräfte

Die meist gesuchten Biographien bei Jaguar Animal Health

• Lisa Conte, Chief Executive Officer, Executive Director
• John Micek, Director
• James Bochnowski, Chairman of the Board

Eine Benachrichtigung erstellen
um Veränderungen bei Führungskräften von Jaguar Animal Health nachzuverfolgen.

Jaguar Animal Health hat 1.838 Konkurrenten , einschließlich Pfizer (USA), Johnson & Johnson (USA) und Sanofi (Frankreich).

Popular M&A news in Pharmazie

• Pathos wird mit seiner 365-Millionen-Dollar-Spendenaktion zum Einhorn. (veröffentlicht am 4, Juli 2025).
• Vor Biopharma and Incyte have announced they will merge  (veröffentlicht am 30, Juni 2025)..
• Supernus Pharmaceuticals has announced the acquisition of Sage Therapeutics  (veröffentlicht am 16, Juni 2025).

Andere vorgeschlagene Kontakte der Pharmazie branche

• Linh Kha - Senior Vice President and General Manager, Japan Asia-Pacific bei Amgen
• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets bei Bristol-Myers Squibb
• Seth Harrison - Chairman and Director bei Braeburn Pharmaceuticals

Mehr über die Pharmazie branche erfahren

Neueste Pressemitteilungen nach Jaguar Animal Health

• Jaguar Health Appoints Senior Healthcare and Investment Executive Dr. Anula Jayasuriya to Board of Directors and Forms Business Development Advisory Committee to Assess Opportunities for Alliances, Mergers, and Acquisitions | Jaguar Health, Inc.
• Jaguar Health Enters Exclusive Crofelemer License and Commercialization Agreement with SynWorld Technologies for Canalevia for Treatment of Diarrhea in Dogs in China | Jaguar Health, Inc.
• Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Jaguar Health, Inc.
• Jaguar Health Announces Online Availability of a Presentation on Short Bowel Syndrome (SBS) by Dr. Mohamad Miqdady at Elite Ped-GI Congress in Abu Dhabi | Jaguar Health, Inc.
• Jaguar Animal Health Exhibiting at the June 23-25 American College of Veterinary Internal Medicine (ACVIM) Forum as Part of Ongoing Commercial Launch Activities for Canalevia-CA1 | Jaguar Health, Inc.
• Jaguar Health Announces Publication of Onco'Zine Article Underscoring the Importance of Controlling Diarrhea in Cancer Patients | Jaguar Health, Inc.
• Jaguar Health Reports Voting Results from 2022 Annual Meeting of Stockholders | Jaguar Health, Inc.
• Jaguar Health to Participate in BIO International Convention (BIO 2022) | Jaguar Health, Inc.
• Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications | Jaguar Health, Inc.
• Jaguar Health Announces Napo Therapeutics' Submission of Orphan Drug Designation Application to the European Medicines Agency for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Condition | Jaguar Health, Inc.
• View more press releases Close

Social media about Jaguar Animal Health

• Jaguar Animal Health auf Wikipedia, Google News & Yahoo Finance
• Jaguar Animal Health auf LinkedIn, Twitter & YouTube